SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.88+1.5%Nov 12 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Solid who wrote (3090)5/31/1998 10:28:00 PM
From: BigKNY3  Read Replies (4) of 9523
 
Solid <<Bigk-How about this one...Zanogen -and does June mean it would be available when? I dislike ambiguous wording as with the 2nd to last paragraph here. I think it means by end of June they will be ASKING for FDA to look into approval. >>

SGP has not submitted the Vasomax NDA to the FDA. Expected submission date this summer. Add one year for a standard review. Accordingly, the earliest Vasomax would be on the market (without FDA questions and assuming an approval) is summer, 1999.

BigKNY3
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext